These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3385216)

  • 21. Skin metabolism established with the use of MetaSite for selected retinoids employed in topical and systemic treatment of various skin disorders and found in cosmeceuticals.
    Słoczyńska K; Gunia-Krzyżak A; Żelaszczyk D; Waszkielewicz AM; Marona H
    Acta Biochim Pol; 2015; 62(2):201-6. PubMed ID: 25856558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of pregnancy on the pharmacokinetic disposition of two aromatic retinoids (etretinate and acitretin) in the rat. I. Intravenous studies.
    Brouwer KR; McNamara PJ
    Drug Metab Dispos; 1989; 17(6):646-51. PubMed ID: 2575501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic retinoid therapy for psoriasis.
    Lowe NJ; Lazarus V; Matt L
    J Am Acad Dermatol; 1988 Jul; 19(1 Pt 2):186-91. PubMed ID: 2970476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinoids: an overview of pharmacokinetics and therapeutic value.
    Gollnick H; Ehlert R; Rinck G; Orfanos CE
    Methods Enzymol; 1990; 190():291-304. PubMed ID: 2150872
    [No Abstract]   [Full Text] [Related]  

  • 25. Percutaneous absorption and distribution of organophosphates (chlorpyrifos and dichlorvos) following dermal exposure and decontamination scenarios using in vitro human skin model.
    Moore CA; Wilkinson SC; Blain PG; Dunn M; Aust GA; Williams FM
    Toxicol Lett; 2014 Aug; 229(1):66-72. PubMed ID: 24910989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclic AMP and cyclic AMP-dependent protein kinase in mouse skin. II. In vitro effects of isotretinoin and etretinate.
    Holian O; Kumar R
    Arch Dermatol Res; 1985; 278(2):161-4. PubMed ID: 3006609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arotinoid Ro 13-6298 and etretin: two new retinoids inferior to isotretinoin in sebum suppression and acne treatment.
    Harms M; Philippe I; Radeff B; Masouyé I; Geiger JM; Saurat JH
    Acta Derm Venereol; 1986; 66(2):149-54. PubMed ID: 2424239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral retinoid therapy for disorders of keratinization: single-centre retrospective 25 years' experience on 23 patients.
    Katugampola RP; Finlay AY
    Br J Dermatol; 2006 Feb; 154(2):267-76. PubMed ID: 16433796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinoid augmentation of bioactive interleukin-1 production by murine keratinocytes.
    Tokura Y; Edelson RL; Gasparro FP
    Br J Dermatol; 1992 May; 126(5):485-95. PubMed ID: 1535214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinoic acid receptor agonist as monotherapy for early-stage mycosis fungoides: does it work?
    Amitay-Laish I; Reiter O; Prag-Naveh H; Kershenovich R; Hodak E
    J Dermatolog Treat; 2019 May; 30(3):258-263. PubMed ID: 29889596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vehicle effects on human stratum corneum absorption and skin penetration.
    Zhang A; Jung EC; Zhu H; Zou Y; Hui X; Maibach H
    Toxicol Ind Health; 2017 May; 33(5):416-425. PubMed ID: 27436841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthetic retinoids inhibit the antigen presenting properties of epidermal cells in vitro.
    Dupuy P; Bagot M; Heslan M; Dubertret L
    J Invest Dermatol; 1989 Oct; 93(4):455-9. PubMed ID: 2528595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retinoid concentrations in skin, serum and adipose tissue of patients treated with etretinate.
    Rollman O; Vahlquist A
    Br J Dermatol; 1983 Oct; 109(4):439-47. PubMed ID: 6226308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic and topical retinoids in the management of skin cancer in organ transplant recipients.
    De Graaf YG; Euvrard S; Bouwes Bavinck JN
    Dermatol Surg; 2004 Apr; 30(4 Pt 2):656-61. PubMed ID: 15061851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Penetration and percutaneous absorption of topical retinoids. A review.
    Schaefer H
    Skin Pharmacol; 1993; 6 Suppl 1():17-23. PubMed ID: 8142107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proliferation and glycosaminoglycans secretion in fibroblasts from psoriatic skin: differential responses to retinoids.
    Priestley GC
    Br J Dermatol; 1987 Nov; 117(5):575-83. PubMed ID: 2961363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of the retinoids isotretinoin and etretinate. A comparative review.
    Brazzell RK; Colburn WA
    J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):643-51. PubMed ID: 6461675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of systemic retinoids in dermatology].
    Fritsch P
    Wien Klin Wochenschr; 1983 Dec; 95(23):817-22. PubMed ID: 6230801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical pharmacology of 3 generations of retinoids.
    Vahlquist A; Rollman O
    Dermatologica; 1987; 175 Suppl 1():20-7. PubMed ID: 3319726
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.